David E. Stockett
Impact in
- Toxicology top 10%
-
- Cancer-related Molecular Pathways
Papers in
-
- Cancer therapeutics and mechanisms 4
- DNA Repair Mechanisms 3
- Advanced biosensing and bioanalysis techniques 1
- Protein Degradation and Inhibitors 1
- Oncology 4
- Cancer-related Molecular Pathways 2
- Neutropenia and Cancer Infections 2
- Co-authors
- Judith A. Fox (5 shared papers)Rachael E. Hawtin (5 shared papers)Michelle R. Arkin (3 shared papers)Andrew Conroy (2 shared papers)Ute Hoch (4 shared papers)Duncan Walker (3 shared papers)Neil Osheroff (1 shared paper)Jo Ann W. Byl (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (1 paper)Oncotarget (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
David E. Stockett
9 papers receiving 388 citations
Peers
Comparison fields: 5 of 58
- Toxicology 25
- Oncology 189
- Hematology 59
- Cell Biology 62
- Molecular Biology 252
Countries citing papers authored by David E. Stockett
This map shows the geographic impact of David E. Stockett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Stockett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Stockett more than expected).
Fields of papers citing papers by David E. Stockett
This network shows the impact of papers produced by David E. Stockett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Stockett. The network helps show where David E. Stockett may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Stockett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 127 | |
| 2 | 2009 | 106 | |
| 3 | E-selectin up-regulation allows for targeted drug delivery in prostate cancer. | 2003 | 54 |
| 4 | 2009 | 53 | |
| 5 | 2010 | 36 | |
| 6 | 2008 | 10 | |
| 7 | 2008 | 5 | |
| 8 | Abstract #1708: Voreloxin is active in breast cancer biopsies and potency is enhanced in a BRCA2 mutant background | 2009 | 1 |
| 9 | 2009 | 1 |
About David E. Stockett
David E. Stockett is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pharmaceutical Science, having authored 9 papers that have together received 393 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (3 papers), Cancer-related Molecular Pathways (2 papers), Neutropenia and Cancer Infections (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Protein Degradation and Inhibitors (1 paper), Plant nutrient uptake and metabolism (1 paper) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Toxicology (25 citations), Oncology (189 citations), Hematology (59 citations), Cell Biology (62 citations) and Molecular Biology (252 citations). David E. Stockett has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Judith A. Fox, Rachael E. Hawtin, Michelle R. Arkin, Andrew Conroy, Ute Hoch, Duncan Walker, Neil Osheroff, Jo Ann W. Byl, Robert S. McDowell and Nguyêñ Duy Tân. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.